Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ludwig Enterprises Inc LUDG

Healthcare Biotechnology
Ludwig Enterprises is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. Advancements in medical technology and Artificial Intelligence (AI) have awarded us with cutting-edge genomic tools, unheard-of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to... see more

Recent & Breaking News (OTCPK:LUDG)

Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study

Accesswire March 27, 2024

Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024

GlobeNewswire March 19, 2024

Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers

GlobeNewswire March 6, 2024

Ludwig Enterprises mRNA Bladder Cancer Study to be Launched

Accesswire January 31, 2024

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

Accesswire January 9, 2024

Ludwig Enterprises Appoints Scott Silverman as CFO

Accesswire November 16, 2023

Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company

Accesswire November 14, 2023

Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer

Accesswire September 19, 2023

LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes

Accesswire May 9, 2023

Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market

Accesswire May 3, 2023

Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan

Accesswire April 25, 2023

Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation

Accesswire April 12, 2023

Decoding mRNA for Early Disease Detection, Treatment & Prevention

Accesswire March 29, 2023

Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange

Accesswire March 23, 2023

Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange

Accesswire March 21, 2023

Ludwig Enterprises Developing New Partnerships to Fuel Growth

Accesswire March 16, 2023

Ludwig Enterprise mRNA Program Generating Broad Clinical Interest

Accesswire March 14, 2023

Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical

Accesswire March 9, 2023

Ludwig Enterprises Develops Program to Support Ketamine Clinics

Accesswire March 7, 2023

New Scientific Evidence Suggests How Chronic Illnesses May Be Prevented

Accesswire February 22, 2023